Tombaugh and McIntyre criteria | |||||||||
---|---|---|---|---|---|---|---|---|---|
MMSE at assessment | |||||||||
< 18 | 18-23 | 24-30 | |||||||
MMSE at screen | < 18 | 237 | (3%) | 56 | (3%) | 2 | (< 0.1%) | ||
18-23 | 132 | (1%) | 451 | (13%) | 228 | (11%) | |||
24-30 | 6 | (< 0.1%) | 208 | (7%) | 955 | (62%) | |||
Folstein et al. criteria | |||||||||
MMSE at assessment | |||||||||
< 10 | 11-20 | 21-26 | 27-30 | ||||||
MMSE at screen | < 10 | 39 | (< 1%) | 13 | (1%) | 0 | 0 | ||
11-20 | 37 | (< 1%) | 373 | (7%) | 122 | (6%) | 3 | (1%) | |
21-26 | 0 | 165 | (3%) | 763 | (31%) | 289 | (12%) | ||
27-30 | 0 | 6 | (< 0.1%) | 145 | (13%) | 320 | (28%) | ||
MRC CFAS criteria | |||||||||
MMSE at assessment | |||||||||
< 18 | 18-22 | 23-26 | 27-30 | ||||||
MMSE at screen | < 18 | 237 | (3%) | 52 | (3%) | 6 | (< 1%) | 0 | |
18-22 | 129 | (1%) | 305 | (8%) | 173 | (7%) | 18 | (1%) | |
23-26 | 8 | (< 0.1%) | 173 | (5%) | 429 | (19%) | 274 | (11%) | |
27-30 | 1 | (< 0.1%) | 16 | (< 1%) | 134 | (12%) | 320 | (28%) |